Transcatheter Heart Valve Replacement Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Transcatheter Heart Valve Market Outlook
Global Transcatheter Heart Valve Replacement Market is estimated to be US$ 15.14 Billion in 2030, according to Renub Research. Over the past decade, the number of bio-prosthetic valve implants has steadily increased, leading to a growing population of patients who may require reoperation due to valve deterioration. In response, valve-in-valve transcatheter aortic valve replacement has emerged as a safe and effective alternative to surgery, specifically approved for higher-risk, inoperable patients. This complex procedure requires skilled personnel and should be performed in specialized centers to mitigate the higher risk of peri- and post-procedural complications compared to TAVR on native valves.
Aortic stenosis, a condition where the aortic valve doesn't fully open, restricts blood flow and necessitates treatment such as transcatheter aortic valve implantation. The rising prevalence of aortic stenosis, coupled with improved surgical techniques and growing demand for surgical technologies, is driving the transcatheter aortic valve replacement (TAVR) market. Increased healthcare investments, globally, are further supporting the market's expansion. Additionally, factors such as the growing acceptance rate of TAVI treatments, new device approvals, and a wealth of clinical evidence on their success are propelling market demand.
Transcatheter Heart Valve Replacement Companies News
Edwards Life sciences
In December 2023, Edwards Lifesciences will spin off its critical care unit at the end of 2024 to concentrate on its larger heart devices business.
In October 2023, Edwards Lifesciences secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive a regulatory green light.
Abbott Laboratories
In Sep 2021, The FDA approved Abbott's Portico™ with FlexNav™ TAVR system for treating severe aortic stenosis in high-risk patients instead of open-heart surgery. This approval reinforces Abbott's leadership in providing structural heart solutions.
In December 2022, Abbott announced that it had launched Navitor, its latest-generation transcatheter aortic valve implantation (TAVI) system, in India.
Medtronic Plc
NOV 2022, the new Evolut™ FX TAVR system from Medtronic has shown significant improvement in commissure alignment during procedures compared to earlier generation Evolut systems. This was reported in a late-breaker presentation at PCR London Valves 2022. The study included 168 patients from six US centers and compared them to 378 Evolut PRO+ patients from a single center.
In February 2023, Medtronic relaunched its Harmony™ Transcatheter Pulmonary Valve (TPV) System, a minimally invasive option for patients with congenital heart disease that affects the right ventricular outflow tract, whether it is natural or surgically repaired.
Boston Scientific Corporation
Jan 2024, Boston Scientific received U.S. regulatory backing for its Farapulse pulsed field ablation system (PFA), a new treatment for atrial fibrillation (AFib) that physicians expect to be widely adopted.
Sept 2023, Boston Scientific announced that its ACCURATE Prime XL Nested Registry completed patient enrollment. The registry evaluates the Acurate Prime aortic valve system, the Marlborough, Massachusetts-based company’s next-generation technology. It enhances the Acurate neo2 transcatheter aortic valve replacement (TAVR) system, including a full-sized matrix. The system treats patients with severe symptomatic aortic stenosis across all surgical risk levels.
Artivion Inc
Oct 2023, Artivion presented data from the post-market study of the On-X aortic heart valve, showing that the valve was safe and effective with low-dose warfarin.
MicroPort Scientific Corporation
Jan 2024, MicroPort® CardioFlow's Transcatheter Mitral Valve Replacement System completed its first clinical application under compassionate use at the Lille University Hospital Center in France.
Jan 2024, FireMagic™ TrueForce™ Ablation Catheter, developed by MicroPortEverPace, successfully completed its first batch of procedures in Europe. It demonstrated its leading technology and superior performance in treating arrhythmias in EU countries, including Spain, Poland, and Greece.
Dec 2023, two atrial fibrillation treatments and one atrial flutter treatment were successfully performed by Professor Emin from Heart Rhythm Management Center at DokuzEylül University using the FireMagic™ TrueForce™ Ablation Catheter (TrueForce™ Ablation Catheter) and the latest version of the Columbus™ 3D EP Navigation System (Columbus™ V3), developed by MicroPort EP. This marked the first clinical application of the TrueForce™ Ablation Catheter in Turkey.
Venus Medtech (Hangzhou) Inc
In February 2024, Health Canada approved China-based Venus Medtech’sVenusP-Valve transcatheter pulmonic valve replacement (TPVR) system.
In August 2023, Venus Medtech Inc. announced the full Investigational Device Exemption (IDE) approval for its in-house developed VenusP-Valve from the U.S. Food and Drug Administration (FDA). VenusP-Valve thus became the first China-developed heart valvular system to be approved by the FDA for clinical trials, setting a new milestone in the global footprint of Chinese valves.
Global Transcatheter Heart Valve Replacement Market is projected to experience a strong compound annual growth rate (CAGR) of 12.72% from 2022 to 2030
The global transcatheter heart valve replacement market is witnessing significant growth due to the rise in the prevalence of valvular heart diseases and the increasing demand for minimally invasive procedures. The aging population, particularly those affected by heart valve diseases, is driving the need for valve replacement surgeries. Advancements in surgical techniques are further contributing to the growth of the transcatheter heart valve replacement market. Favorable reimbursement policies and the growing interest of manufacturers are also boosting market revenue.
However, strict regulations for the approval of transcatheter aortic valves and the high cost of TAVI procedures pose challenges to market expansion. Nevertheless, the use of TAVI systems for new indications, increased healthcare spending in emerging economies, and the involvement of key players in the global TAVI industry are expected to create growth opportunities throughout the forecast period. The global transcatheter heart valve replacement market was valued at US$ 5.81 Billion in 2022.
Market share of TAVR is expected to continue its upward trajectory in the global healthcare landscape
By Type, Transcatheter Heart Valve Replacement Market is divided into TAVR, TMVR and TPVR. Transcatheter Aortic Valve Replacement (TAVR) has emerged as a leading procedure in the global medical market, capturing the highest market share. The increasing prevalence of cardiovascular diseases, particularly aortic valve disorders, has contributed to the rising demand for TAVR procedures. This minimally invasive technique offers numerous benefits, including reduced hospital stay, faster recovery time, and improved patient outcomes.
Moreover, advancements in TAVR device technologies, coupled with the growing acceptance of this procedure among healthcare professionals, have further fueled its market dominance. With ongoing research and development efforts and a favorable reimbursement landscape, the TAVR market is projected to maintain its significant market share in the foreseeable future.
Biological tissue market segment is experiencing rapid growth within the Transcatheter Aortic Valve Replacement (TAVR) industry
By Material, Transcatheter Heart Valve Replacement Market is segmented into Mechanical valves and Biological tissue. The biological tissue market within the Transcatheter Aortic Valve Replacement (TAVR) industry is experiencing rapid growth and emerging as the fastest-growing segment. Biological tissue valves, also known as bioprosthetic valves, offer advantages such as improved durability and reduced risk of blood clots compared to mechanical valves. This has led to increased adoption of biological tissue valves in TAVR procedures, especially among elderly patients who require valve replacement. The market growth is further fueled by advancements in tissue engineering, which have led to the development of more durable and long-lasting biological tissue valves. With ongoing research and technological innovations, the biological tissue market is poised to continue its upward trajectory within the TAVR industry.
Growing prominence of ASCs is expected to reshape the landscape of TAVR and drive its rapid expansion in the coming years
By End User, Transcatheter Heart Valve Replacement Market is classified into Hospital, Ambulatory surgical centers and others. The ambulatory surgical centers (ASCs) segment is emerging as the fastest growing sector within the Transcatheter Aortic Valve Replacement (TAVR) industry. ASCs provide a convenient and cost-effective alternative to traditional hospital settings for performing TAVR procedures.
With advancements in medical technology and improved patient outcomes, more TAVR procedures can now be safely conducted in outpatient settings. ASCs offer shorter hospital stays, reduced healthcare costs, and greater accessibility for patients. Additionally, ASCs focus on delivering specialized care and personalized patient experiences, attracting more physicians and patients to choose these centers for TAVR procedures.
Transcatheter Aortic Valve Replacement (TAVR) industry in India is rapidly evolving and witnessing significant growth
By Countries, Transcatheter Heart Valve Replacement Market is breakup into US, Canada, Mexico, Brazil, Argentina, Germany, Spain, United Kingdom, Italy, France, Indonesia, Malaysia, India, Thailand, Japan, China, South Korea, Australia, New Zealand, South Africa, Saudi Arabia, UAE, Turkey and Rest of the world. The United States Transcatheter Aortic Valve Replacement (TAVR) industry is experiencing significant growth and innovation. With a rising prevalence of aortic valve diseases and an aging population, TAVR has emerged as a preferred alternative to traditional open-heart surgery.
The market is driven by advanced medical technologies, a robust healthcare infrastructure, and a favorable reimbursement landscape. Major medical device companies, research institutions, and healthcare providers are actively engaged in expanding TAVR procedures and improving patient outcomes. Continuous advancements in device design, minimally invasive techniques, and clinical research are propelling the growth of the United States TAVR industry, positioning it as a global leader in this life-saving procedure.
With a large population and increasing prevalence of aortic valve diseases, there is a growing need for advanced treatment options like TAVR. The market is characterized by a rising number of medical institutions offering TAVR procedures, advancements in healthcare infrastructure, and increased awareness among healthcare professionals and patients. Government initiatives and favorable reimbursement policies are further fueling the growth of the TAVR industry in India. With continuous advancements in technology, increasing collaborations with international medical device companies, and ongoing research and development efforts, the Indian TAVR industry is poised for significant expansion and plays a vital role in improving cardiac care in the country.
Key Company
In the Valve Replacement (TAVR) industry, several key players have emerged as industry leaders. Edwards Life Sciences, Abbott Laboratories, Medtronic Plc, LIVANOVA PLC, Boston Scientific Corporation, Artivion, Inc, MicroPort Scientific Corporation, and Venus Medtech (Hangzhou) Inc are among the prominent companies driving innovation and advancements in this field.
Transcatheter Heart Valve Replacement Market by Type has been covered from 3 viewpoints
1. Transcatheter Aortic Valve Replacement
2. Transcatheter Mitral Valve Replacement
3. Transcatheter Pulmonary Valve Replacement
Transcatheter Aortic Valve Replacement Market has been covered from 2 viewpoints
1. Mechanical Valve
2. Biological Valve
Transcatheter Mitral Valve Replacement Market has been covered from 2 viewpoints
1. Mechanical Valve
2. Biological Valve
Transcatheter Pulmonary Valve Replacement Market has been covered from 2 viewpoints
1. Mechanical Valve
2. Biological Valve
By Country – Transcatheter Heart Valve Replacement Market
1. North America
1.1 United States
1.2 Canada
2. Latin America
2.1 Mexico
2.2 Brazil
2.3 Argentina
3. Europe
3.1 Germany
3.2 Spain
3.3 United Kingdom
3.4 Italy
3.5 France
3.6 Turkey
4. Asia Pacific
4.1 Indonesia
4.2 Malaysia
4.3 India
4.4 Thailand
4.5 Japan
4.6 China
4.7 South Korea
4.8 Australia
4.9 New Zealand
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 UAE
6. Rest of the World
Transcatheter Heart Valve Replacement Market by End-User has been covered from 3 viewpoints
1. Hospital
2. Ambulatory surgical centers
3. Others
Company Insights
• Overviews
• Recent Developments
• Revenues
Company:
1. Edwards Life sciences
2. Abbott Laboratories
3. Medtronic Plc
4. LIVANOVA PLC
5. Boston Scientific Corporation
6. Artivion, Inc,
7. MicroPort Scientific Corporation
8. Venus Medtech (Hangzhou) Inc.
Report Details:
Report Features | Details |
Base Year | 2022 |
Historical Period | 2018 - 2022 |
Forecast Period | 2023 - 2030 |
Market | US$ Billion |
Segment Covered | Type, Material, End-Users, Countries, Product, and Application |
Countries Covered | USA, Canada, Mexico, Brazil, Argentina, Germany, Spain, United Kingdom, Italy, France, Turkey, Indonesia, Malaysia, India, Thailand, Japan, China, South Korea, Australia, New Zealand, South Africa, Saudi Arabia, UAE and Rest of the World |
Companies Covered | Edwards Life sciences, Abbott Laboratories, Medtronic Plc, LIVANOVA PLC, Boston Scientific Corporation, Artivion, Inc, MicroPort Scientific Corporation and Venus Medtech (Hangzhou) Inc. |
Customization Scope | 20% Free Customization |
Post-Sale Analyst Support | 1 Year (52 Weeks) |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenge
5. Transcatheter Heart Valve Replacement Market
6. Share Analysis – Transcatheter Heart Valve Replacement Market
6.1 THVR Market Share by Type
6.2 THVR Market Share by Material
6.3 THVR Market Share by End User
6.4 THVR Market Share by Countries
6.5 TAVR Market Share by Product
6.6 TAVR Market Share by Application
7. Type – Transcatheter Heart Valve Replacement Market
7.1 TranscatheterAortic Valve Replacement
7.2 Transcatheter MitralValve Replacement
7.3 Transcatheter PulmonaryValve Replacement
8. Material – Transcatheter Heart Valve Replacement Market
8.1 Mechanical valves
8.2 Biological Valves
9. End-User – Transcatheter Heart Valve Replacement Market
9.1 Hospitals
9.2 Ambulatory Surgical Centers
9.3 Others
10. Countries – Transcatheter Aortic Heart Valve Replacement Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Latin America
10.2.1 Mexico
10.2.2 Brazil
10.2.3 Argentina
10.3 Europe
10.3.1 Germany
10.3.2 Spain
10.3.3 United Kingdom
10.3.4 Italy
10.3.5 France
10.3.6 Turkey
10.4 Asia Pacific
10.4.1 Indonesia
10.4.2 Malaysia
10.4.3 India
10.4.4 Thailand
10.4.5 Japan
10.4.6 China
10.4.7 South Korea
10.4.8 Australia
10.4.9 New Zealand
10.5 Middle East & Africa
10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 UAE
10.6 Rest of the World
11. Product – Transcatheter Aortic Heart Valve Replacement Market
11.1 Transfemoral approach
11.2 Transapical approach
11.3 Transaortic approach
11.4 Others
12. Application – Transcatheter Aortic Heart Valve Replacement Market
12.1 Aortic Stenosis
12.2 Aortic Regurgitation
12.3 Others
13. Porter’s Five Forces Analysis – Transcatheter Heart Valve Replacement Market
13.1 Bargaining Power of Buyers
13.2 Bargaining Power of Suppliers
13.3 Degree of Rivalry
13.4 Threat of New Entrants
13.5 Threat of Substitutes
14. SWOT Analysis – Transcatheter Heart Valve Replacement Market
14.1 Strength
14.2 Weakness
14.3 Opportunity
14.4 Threat
15. Key Players Analysis
15.1 Edwards Lifesciences
15.1.1 Overview
15.1.2 Recent Development
15.1.3 SWOT Analysis
15.1.4 Sales Analysis
15.2 Abbott Laboratories
15.2.1 Overview
15.2.2 Recent Development
15.2.3 SWOT Analysis
15.2.4 Sales Analysis
15.3 Medtronic Plc
15.3.1 Overview
15.3.2 Recent Development
15.3.3 SWOT Analysis
15.3.4 Sales Analysis
15.4 LIVANOVA PLC
15.4.1 Overview
15.4.2 Recent Development
15.4.3 SWOT Analysis
15.4.4 Sales Analysis
15.5 Boston Scientific Corporation
15.5.1 Overview
15.5.2 Recent Development
15.5.3 SWOT Analysis
15.5.4 Sales Analysis
15.6 Artivion, Inc.
15.6.1 Overview
15.6.2 Recent Development
15.6.3 SWOT Analysis
15.6.4 Sales Analysis
15.7 MicroPort Scientific Corporation
15.7.1 Overview
15.7.2 Recent Development
15.7.3 SWOT Analysis
15.7.4 Sales Analysis
15.8 Venus Medtech (Hangzhou) Inc
15.8.1 Overview
15.8.2 Recent Development
15.8.3 SWOT Analysis
15.8.4 Sales Analysis
List of Figures:
Figure-01: Global Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-02: Global – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-03: Type – Transcatheter Aortic Valve Replacement Market Market (Million US$), 2018 – 2022
Figure-04: Type – Forecast for Transcatheter Aortic Valve Replacement Market Market (Million US$), 2023 – 2030
Figure-05: Type – Transcatheter Mitral Valve Replacement Market Market (Million US$), 2018 – 2022
Figure-06: Type – Forecast for Transcatheter Mitral Valve Replacement Market Market (Million US$), 2023 – 2030
Figure-07: Type – Transcatheter Pulmonary Valve Replacement Market Market (Million US$), 2018 – 2022
Figure-08: Type – Forecast for Transcatheter Pulmonary Valve Replacement Market Market (Million US$), 2023 – 2030
Figure-09: Material – Mechanical Valve Market (Million US$), 2018 – 2022
Figure-10: Material – Forecast for Mechanical Valve Market (Million US$), 2023 – 2030
Figure-11: Material – Biological Valve Market (Million US$), 2018 – 2022
Figure-12: Material – Forecast for Biological Valve Market (Million US$), 2023 – 2030
Figure-13: End-User – Hospitals Market (Million US$), 2018 – 2022
Figure-14: End-User – Forecast for Hospitals Market (Million US$), 2023 – 2030
Figure-15: End-User – Ambulatory Surgical Centers Market (Million US$), 2018 – 2022
Figure-16: End-User – Forecast for Ambulatory Surgical Centers Market (Million US$), 2023 – 2030
Figure-17: End-User – Others Market (Million US$), 2018 – 2022
Figure-18: End-User – Forecast for Others Market (Million US$), 2023 – 2030
Figure-19: United States – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-20: United States – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-21: Canada – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-22: Canada – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-23: Mexico – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-24: Mexico – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-25: Brazil – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-26: Brazil – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-27: Argentina – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-28: Argentina – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-29: Germany – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-30: Germany – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-31: Spain – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-32: Spain – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-33: United Kingdom – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-34: United Kingdom – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-35: Italy – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-36: Italy – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-37: France – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-38: France – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-39: Turkey – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-40: Turkey – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-41: Indonesia – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-42: Indonesia – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-43: Malaysia – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-44: Malaysia – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-45: India – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-46: India – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-47: Thailand – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-48: Thailand – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-49: Japan – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-50: Japan – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-51: China – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-52: China – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-53: South Korea – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-54: South Korea – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-55: Australia – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-56: Australia – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-57: New Zealand – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-58: New Zealand – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-59: South Africa – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-60: South Africa – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-61: Saudi Arabia – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-62: Saudi Arabia – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-63: UAE – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-64: UAE – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-65: Rest of the World – Transcatheter Heart Valve Replacement Market (Million US$), 2018 – 2022
Figure-66: Rest of the World – Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 – 2030
Figure-67: Product – Transfemoral Approach Market (Million US$), 2018 – 2022
Figure-68: Product – Forecast for Transfemoral Approach Market (Million US$), 2023 – 2030
Figure-69: Product – Transapical Approach Market (Million US$), 2018 – 2022
Figure-70: Product – Forecast for Transapical Approach Market (Million US$), 2023 – 2030
Figure-71: Product – Transaortic Approach Market (Million US$), 2018 – 2022
Figure-72: Product – Forecast for Transaortic Approach Market (Million US$), 2023 – 2030
Figure-73: Product – Others Market (Million US$), 2018 – 2022
Figure-74: Product – Forecast for Others Market (Million US$), 2023 – 2030
Figure-75: Application – Aortic Stenosis Market (Million US$), 2018 – 2022
Figure-76: Application – Forecast for Aortic Stenosis Market (Million US$), 2023 – 2030
Figure-77: Application – Aortic Regurgitation Market (Million US$), 2018 – 2022
Figure-78: Application – Forecast for Aortic Regurgitation Market (Million US$), 2023 – 2030
Figure-79: Application – Others Market (Million US$), 2018 – 2022
Figure-80: Application – Forecast for Others Market (Million US$), 2023 – 2030
Figure-81: Edwards Lifesciences – Global Revenue (Million US$), 2018 – 2022
Figure-82: Edwards Lifesciences – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-83: Abbott Laboratories – Global Revenue (Million US$), 2018 – 2022
Figure-84: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-85: Medtronic Plc – Global Revenue (Million US$), 2018 – 2022
Figure-86: Medtronic Plc – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-87: LIVANOVA PLC – Global Revenue (Million US$), 2018 – 2022
Figure-88: LIVANOVA PLC – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-89: Boston Scientific Corporation – Global Revenue (Million US$), 2018 – 2022
Figure-90: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-91: Artivion, Inc. – Global Revenue (Million US$), 2018 – 2022
Figure-92: Artivion, Inc. – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-93: MicroPort Scientific Corporation – Global Revenue (Million US$), 2018 – 2022
Figure-94: MicroPort Scientific Corporation – Forecast for Global Revenue (Million US$), 2023 – 2030
Figure-95: Venus Medtech (Hangzhou) Inc – Global Revenue (Million US$), 2018 – 2022
Figure-96: Venus Medtech (Hangzhou) Inc – Forecast for Global Revenue (Million US$), 2023 – 2030
List of Tables:
Table-01: Global – Transcatheter Heart Valve Replacement Market Share by Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by Type (Percent), 2023 – 2030
Table-03: Global – Transcatheter Heart Valve Replacement Market Share by Material (Percent), 2018 – 2022
Table-04: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by Material (Percent), 2023 – 2030
Table-05: Global – Transcatheter Heart Valve Replacement Market Share by End-User (Percent), 2018 – 2022
Table-06: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by End-User (Percent), 2023 – 2030
Table-07: Global – Transcatheter Heart Valve Replacement Market Share by Countries (Percent), 2018 – 2022
Table-08: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by Countries (Percent), 2023 – 2030
Table-09: Global – Transcatheter Heart Valve Replacement Market Share by Product (Percent), 2018 – 2022
Table-10: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by Product (Percent), 2023 – 2030
Table-11: Global – Transcatheter Heart Valve Replacement Market Share by Application (Percent), 2018 – 2022
Table-12: Global – Forecast for Transcatheter Heart Valve Replacement Market Share by Application (Percent), 2023 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com